Astrazeneca Pharma India Share Price
Small Cap | Pharmaceuticals and health care | NSE: ASTRAZEN | BSE: 506820
₹6,853.00 
-123.50 (-1.77 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 7,117.00
High (₹) 7,117.00
Low (₹) 6,803.60
Prev. Close (₹) 6,976.50
Volume 384
VWAP (₹) 6,867.09
ROCE (%) 28.34
Industry P/E 43.99
TTM P/E 176.67
P/B Ratio 24.13
Market Cap (₹) Cr.17,175.75
Dividend Yield (%)0.35
EPS (₹) 64.60
ROE22.68%
Sales Growth (%) 29.17
Profit Growth (%)62.66
Day Range
7,117.007,117.00
52 Week Range
4,050.158,139.85
Historical Returns
Returns (6M)
-0.18 %
Returns (1Y)
24.66 %
Returns (3Y)
160.31 %
Returns (5Y)
148.77 %
Returns (6M)
-0.18 %
Returns (1Y)
24.66 %
Returns (3Y)
160.31 %
Returns (5Y)
148.77 %
SWOT Analysis
- Increasing Revenue every Quarter for the past 4 Quarters
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
Technicals
Technical Rating
BEARISHRSI 25.23
MFI 45.37
ATR 253.66
Commodity Channel Index -113.14
ROC125 0.12
ROC21 -0.88
Williams %R -82.54
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 7,055.96 | 7,243.18 | 7,369.36 | 6,929.78 | 6,742.56 | 6,616.38 | 6,429.16 |
| Week Ago | 7,310.05 | 7,523.75 | 7,645.35 | 7,188.45 | 6,974.75 | 6,853.15 | 6,639.45 |
| Month Ago | 6,915.09 | 7,049.57 | 7,149.94 | 6,814.72 | 6,680.24 | 6,579.87 | 6,445.39 |
EMA & SMA
6853.00
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
18
5 Day 6980.15
9 Day 7203.99
10 Day 7242.89
12 Day 7308.71
14 Day 7317.29
20 Day 7261.99
26 Day 7189.51
50 Day 7000.84
100 Day 7103.69
200 Day 6789.43
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 19 Sept, 2022 | ₹3,152.55 | 6,542 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 19 Sept, 2022 | ₹3,152.55 | 74,097 | BSE |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 19 Sept, 2022 | ₹3,152.55 | 6,542 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 19 Sept, 2022 | ₹3,152.55 | 74,097 | BSE |
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 27 May, 2024 | Rs.24.0000 per share(1200%)Dividend | 05 Jul, 2024 | 05 Jul, 2024 |
| 30 May, 2023 | Rs.16.0000 per share(800%)Dividend | 14 Jul, 2023 | 14 Jul, 2023 |
| 26 May, 2022 | Rs.8.0000 per share(400%)Final Dividend | 07 Jul, 2022 | 08 Jul, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 17 Feb, 2025 | NSE India | Please find the enclosed Financial Results of the Company for the quarter and nine months ended December 31, 2024. |
| 14 Feb, 2025 | NSE India | AstraZeneca Pharma India Limited has informed the Exchange about Copy of Newspaper Publication |
| 11 Feb, 2025 | BSE India | Please find the enclosed document as per the captioned subject for your reference. |
| 11 Feb, 2025 | NSE India | AstraZeneca Pharma India Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
| 11 Feb, 2025 | BSE India | Please find the enclosed document as per the captioned subject for your reference. |
| 11 Feb, 2025 | NSE India | AstraZeneca Pharma India Limited has informed the Exchange regarding a press release dated February 11, 2025, titled ""Press Release"". |
| 11 Feb, 2025 | BSE India | At the Board meeting of the Company held on Tuesday, February 11, 2025, the Board of Directors considered and approved the unaudited financial results of the Company for the quarter ended December 31, 2024. The said unaudited financial results together with the Limited Review Report of the Statutory Auditors dated December 31, 2024 are enclosed herewith. |
| 11 Feb, 2025 | NSE India | AstraZeneca Pharma India Limited has informed the Exchange regarding Board meeting held on February 11, 2025. |
| 11 Feb, 2025 | NSE India | AstraZeneca Pharma India Limited has informed the Exchange about General Updates |
| 11 Feb, 2025 | NSE India | AstraZeneca Pharma India Limited has informed the Exchange about General Updates |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 21 Jan, 2025 | 11 Feb, 2025 |
| Quarterly Results | -- | 28 Oct, 2024 | 13 Nov, 2024 |
| Quarterly Results | -- | 25 Jul, 2024 | 08 Aug, 2024 |
| Audited Results & Dividend | -- | 16 May, 2024 | 27 May, 2024 |
| Quarterly Results | -- | 30 Jan, 2024 | 08 Feb, 2024 |
| Quarterly Results | -- | 31 Oct, 2023 | 09 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 14 Aug, 2023 |
| Audited Results & Dividend | -- | 24 May, 2023 | 30 May, 2023 |
| Quarterly Results | -- | 31 Jan, 2023 | 10 Feb, 2023 |
| Quarterly Results | -- | 31 Oct, 2022 | 11 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Astrazeneca Pharma India
AstraZeneca Pharma India is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1295.53 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
AstraZeneca Group
Founded
1979
Managing Director
-- --
NSE Symbol
ASTRAZEN
Astrazeneca Pharma India Management
| Name | Designation |
|---|---|
| Mr. Narayan K Seshadri | Chairperson & Independent Director |
| Mr. Sanjeev Kumar Panchal | Executive Director |
| Ms. Bhavana Agrawal | Executive Director |
| Ms. Sylvia Lorena Varela Ramon | Non Executive Director |
| Ms. Hooi Bien Chuah | Non Executive Director |
| Ms. Shilpa Divekar Nirula | Independent Director |
| Ms. Revathy Ashok | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,643.75  ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Astrazeneca Pharma India
What is the share price of Astrazeneca Pharma India?
The share price of Astrazeneca Pharma India on 21 Feb, 2025 is ₹ 6,853.00.
What is 52W high and 52W low share price of Astrazeneca Pharma India?
The highest and lowest 52W share prices of Astrazeneca Pharma India are ₹ 8139.850 and ₹ 4050.150
What is the market cap of Astrazeneca Pharma India?
The market capitalization of Astrazeneca Pharma India as of 21 Feb, 2025 is ₹ 17,175.75 Crores
What is the P/E ratio of Astrazeneca Pharma India?
The current P/E ratio of Astrazeneca Pharma India as of 21 Feb, 2025 is 43.99
What is the PB ratio of Astrazeneca Pharma India?
The PB ratio of Astrazeneca Pharma India as of 21 Feb, 2025 is 24.13
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)